Birdwatch Note
2024-03-31 09:13:12 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
小林製薬はワクチンの製造を断った、というのはデマです。 小林製薬が扱っている医薬品は一般消費者向けです。 元々ワクチンを製造しておらず、製造を断るという状況はあり得ません。 医療機関・医師への小林製薬の支払額の情報が出てこないのも同様の理由です。 小林製薬の医薬品一覧 https://www.qlife.jp/meds/maker/183/1/ 小林製薬 統合報告書2022.12 https://www.kobayashi.co.jp/ir/report/annualreport/pdf/KobayashiS_ar_2022_japanese_a3_4.pdf.pdf 小林製薬 2022年12月期 有価証券報告書 https://www.kobayashi.co.jp/ir/report/asr/pdf/2022_4yuho.pdf
Written by A71C7604A85D2B14280723049D0EF96C5A4BA60970EA8E9221AD0EDA5AC6FEC2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1774255591374148020
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1774364309075706102
- noteId - 1774364309075706102
- participantId -
- noteAuthorParticipantId - A71C7604A85D2B14280723049D0EF96C5A4BA60970EA8E9221AD0EDA5AC6FEC2 Participant Details
- createdAtMillis - 1711876392035
- tweetId - 1774255591374148020
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 小林製薬はワクチンの製造を断った、というのはデマです。 小林製薬が扱っている医薬品は一般消費者向けです。 元々ワクチンを製造しておらず、製造を断るという状況はあり得ません。 医療機関・医師への小林製薬の支払額の情報が出てこないのも同様の理由です。 小林製薬の医薬品一覧 https://www.qlife.jp/meds/maker/183/1/ 小林製薬 統合報告書2022.12 https://www.kobayashi.co.jp/ir/report/annualreport/pdf/KobayashiS_ar_2022_japanese_a3_4.pdf.pdf 小林製薬 2022年12月期 有価証券報告書 https://www.kobayashi.co.jp/ir/report/asr/pdf/2022_4yuho.pdf
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-03-31 09:13:12 UTC (1711876392035) |
2024-03-31 17:40:33 UTC (1711906833110) |
CURRENTLY_RATED_HELPFUL | 2024-04-01 03:14:14 UTC (1711941254008) |
CURRENTLY_RATED_HELPFUL | 2024-03-31 17:40:33 UTC (1711906833110) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-03-31 20:44:14 -0500 | Rating Details | |
2024-03-31 20:43:35 -0500 | Rating Details | |
2024-03-31 20:33:08 -0500 | Rating Details | |
2024-03-31 20:20:18 -0500 | Rating Details | |
2024-03-31 19:59:26 -0500 | Rating Details | |
2024-03-31 19:12:47 -0500 | Rating Details | |
2024-03-31 19:04:52 -0500 | Rating Details | |
2024-03-31 19:01:28 -0500 | Rating Details | |
2024-03-31 18:55:52 -0500 | Rating Details | |
2024-03-31 18:50:26 -0500 | Rating Details | |
2024-03-31 18:49:50 -0500 | Rating Details | |
2024-03-31 18:09:05 -0500 | Rating Details | |
2024-03-31 13:21:03 -0500 | Rating Details | |
2024-03-31 11:47:22 -0500 | Rating Details | |
2024-03-31 10:14:14 -0500 | Rating Details | |
2024-03-31 08:16:23 -0500 | Rating Details | |
2024-03-31 07:49:18 -0500 | Rating Details | |
2024-03-31 06:08:46 -0500 | Rating Details | |
2024-03-31 06:02:06 -0500 | Rating Details | |
2024-03-31 05:46:30 -0500 | Rating Details | |
2024-03-31 05:25:00 -0500 | Rating Details | |
2024-03-31 05:07:49 -0500 | Rating Details | |
2024-03-31 04:55:56 -0500 | Rating Details | |
2024-03-31 04:45:41 -0500 | Rating Details | |
2024-03-31 04:43:12 -0500 | Rating Details | |
2024-03-31 04:43:03 -0500 | Rating Details | |
2024-03-31 04:42:10 -0500 | Rating Details | |
2024-03-31 04:42:09 -0500 | Rating Details | |
2024-03-31 04:40:59 -0500 | Rating Details | |
2024-03-31 04:39:55 -0500 | Rating Details | |
2024-03-31 04:36:24 -0500 | Rating Details | |
2024-03-31 04:35:39 -0500 | Rating Details | |
2024-03-31 04:30:38 -0500 | Rating Details | |
2024-03-31 04:30:13 -0500 | Rating Details | |
2024-03-31 04:28:36 -0500 | Rating Details | |
2024-03-31 04:28:35 -0500 | Rating Details | |
2024-04-01 07:16:57 -0500 | Rating Details | |
2024-04-01 04:02:35 -0500 | Rating Details | |
2024-03-31 23:42:16 -0500 | Rating Details | |
2024-03-31 22:53:25 -0500 | Rating Details | |
2024-03-31 21:33:43 -0500 | Rating Details | |
2024-03-31 21:15:58 -0500 | Rating Details | |
2024-03-31 21:09:37 -0500 | Rating Details | |
2024-03-31 20:26:15 -0500 | Rating Details | |
2024-03-31 19:24:56 -0500 | Rating Details | |
2024-03-31 18:49:46 -0500 | Rating Details | |
2024-03-31 09:41:39 -0500 | Rating Details | |
2024-03-31 08:42:11 -0500 | Rating Details | |
2024-03-31 08:37:38 -0500 | Rating Details | |
2024-03-31 07:46:35 -0500 | Rating Details | |
2024-03-31 07:26:24 -0500 | Rating Details | |
2024-03-31 07:21:10 -0500 | Rating Details | |
2024-03-31 07:17:10 -0500 | Rating Details | |
2024-03-31 07:15:12 -0500 | Rating Details | |
2024-03-31 05:49:40 -0500 | Rating Details | |
2024-03-31 05:41:17 -0500 | Rating Details | |
2024-03-31 05:26:47 -0500 | Rating Details | |
2024-03-31 05:25:30 -0500 | Rating Details | |
2024-03-31 05:19:49 -0500 | Rating Details | |
2024-03-31 05:13:56 -0500 | Rating Details | |
2024-03-31 05:07:17 -0500 | Rating Details | |
2024-03-31 05:06:01 -0500 | Rating Details | |
2024-03-31 04:55:50 -0500 | Rating Details | |
2024-03-31 04:53:56 -0500 | Rating Details | |
2024-03-31 04:49:24 -0500 | Rating Details | |
2024-03-31 04:49:00 -0500 | Rating Details | |
2024-03-31 04:46:07 -0500 | Rating Details | |
2024-03-31 04:38:35 -0500 | Rating Details | |
2024-03-31 04:31:39 -0500 | Rating Details | |
2024-03-31 04:31:06 -0500 | Rating Details | |
2024-04-01 22:12:27 -0500 | Rating Details | |
2024-03-31 17:59:27 -0500 | Rating Details | |
2024-04-08 21:30:06 -0500 | Rating Details | |
2024-04-01 06:12:52 -0500 | Rating Details | |
2024-04-01 17:59:56 -0500 | Rating Details | |
2024-04-01 16:52:54 -0500 | Rating Details | |
2024-04-01 05:58:51 -0500 | Rating Details | |
2024-04-01 04:22:53 -0500 | Rating Details | |
2024-04-01 00:23:56 -0500 | Rating Details | |
2024-03-31 22:12:42 -0500 | Rating Details | |
2024-07-06 09:21:39 -0500 | Rating Details |